For instance, m6A Reader YTHDF2 can promote the non-small cell lung cancer (NSCLC) progression (Sheng et al., 2019), while the Eraser ALKBH5 can inhibit the metastasis of NSCLC by inhibiting the miR-107/LATS2-mediated YAP activity (Jin et al., 2020). This evidence concerns the gene LATS2 and non-small cell lung carcinoma.